Clinical Trials

20 enrolled

Lung Neoplasms

NCT04081688 2026-02-05

Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC

Phase 1 Terminated

16 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07309276 2025-12-30

A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer

864 enrolled

Advanced Lung Cancer

NCT05664971 2025-12-02

JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer

Phase 1/2 Completed

119 enrolled

BreastGastrointestinalGynecologicThoracic

Advanced Lung Cancer

NCT04778839 2025-08-06

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Phase 1 Recruiting

98 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms

NCT06199895 2025-06-03

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Phase 2 Recruiting

25 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT04996017 2025-03-13

AtezoMeso

Phase 3 Recruiting

162 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT06045767 2024-06-03

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer

30 enrolled

Phase 1/2 Active not recruiting

Non-small Cell Lung Cancer Metastatic

NCT04487756 2024-04-03

VENEZO-LUNG

20 enrolled

Small Cell Lung Carcinoma

NCT04209868 2024-03-29

ParaSOL

Phase 2/3 Unknown

100 enrolled

Thoracic Neoplasms

NCT06299371 2024-03-07

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05782426 2023-03-23

Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC

28 enrolled

Non-squamous NSCLC

NCT05631028 2023-03-14

95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment

Phase NA Completed

115 enrolled

Lung Neoplasms

NCT04571632 2022-09-14

Luscid

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05023837 2022-01-25

Esporta

Completed

40 enrolled

Uncommon Pathological Types of Lung Cancer

NCT04840290 2021-04-21

A Neoadjuvant Study of Sintilimab Plus Platinum Doublet Chemotherapy in IIIA(N2) Stage NSCLC

Phase 3 Unknown

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04167774 2019-11-22

Compass-001

62 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02603003 2019-09-20

CTC-TCM-FZ

Phase 1 Completed

218 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT03351842 2017-12-19

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Phase 2 Recruiting

460 enrolled

Adenocarcinoma of Lung, Neoplasms by Histologic Type

NCT01660399 2015-12-22

Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy

300 enrolled

Squamous Cell Lung Cancer

NCT02223611 2014-08-22

S1VSNP

100 enrolled